• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2006 年至 2019 年台湾产前筛查检测对产前诊断的影响:一项区域性队列研究。

The impact of prenatal screening tests on prenatal diagnosis in Taiwan from 2006 to 2019: a regional cohort study.

机构信息

Department of Obstetrics and Gynecology, Taipei City Hospital, Women and Children Campus, 155 Linong Street, Sec. 2, Beitou, Taipei, 112, Taiwan.

Departmen of Biomedical Engineering, National Yang Ming Chiao Tung University, 155 Linong Street, Sec. 2, Beitou, Taipei, 112, Taiwan.

出版信息

BMC Pregnancy Childbirth. 2022 Jan 9;22(1):23. doi: 10.1186/s12884-021-04360-w.

DOI:10.1186/s12884-021-04360-w
PMID:35012459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8744294/
Abstract

BACKGROUND

The purpose of this study is to evaluate the impact of prenatal screening tests on prenatal diagnosis in Taiwan's 14 years from 2006 to 2019.

METHODS

The prenatal screening methods evolved from the second-trimester serum screening to combined first-trimester screening (cFTS) and then followed by the non-invasive cell-free DNA prenatal test (NIPT). The data used by the Department of Statistics, the Ministry of Health and Welfare and Department of Household Registration, Ministry of the Interior public website.

RESULTS

This regional registry-based cohort retrospective study examined a total of 2,775,792 births from January 2006 to December 2019. The proportion of advanced maternal age (AMA) pregnancies increased from 11.63% in 2006 to 30.94% in 2019. Overall, invasive diagnostic testing was used in 87.22% of AMA pregnancies. The prenatal detection rate of trisomy 21 and 18 increased from 74.1% and 83.3% in 2006 to 96.9% and 98.8% in 2019, respectively.

CONCLUSION

During the second-trimester and cFTS periods, the percentage of AMA pregnancies increased every year and the number of invasive procedures also accompany with increased percentage of AMA. However, during the period that NIPT were implemented, the percentage of invasive procedures decreased.

摘要

背景

本研究旨在评估 2006 年至 2019 年台湾 14 年来产前筛查试验对产前诊断的影响。

方法

产前筛查方法从孕中期血清筛查发展为联合孕早期筛查(cFTS),随后是无创性游离胎儿 DNA 产前检测(NIPT)。本研究使用了卫生福利部统计处、内政部户政司公共网站的数据。

结果

本区域注册队列回顾性研究共纳入了 2775792 例 2006 年 1 月至 2019 年 12 月的分娩。高龄产妇(AMA)妊娠的比例从 2006 年的 11.63%增加到 2019 年的 30.94%。总体而言,AMA 妊娠中侵袭性诊断检测的使用率为 87.22%。21 三体和 18 三体的产前检出率从 2006 年的 74.1%和 83.3%分别增加到 2019 年的 96.9%和 98.8%。

结论

在中孕期和 cFTS 期间,AMA 妊娠的比例每年都在增加,侵袭性操作的数量也伴随着 AMA 比例的增加而增加。然而,在 NIPT 实施期间,侵袭性操作的比例有所下降。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f3d/8744294/0de1d637b4f8/12884_2021_4360_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f3d/8744294/87e98d686918/12884_2021_4360_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f3d/8744294/0de1d637b4f8/12884_2021_4360_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f3d/8744294/87e98d686918/12884_2021_4360_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f3d/8744294/0de1d637b4f8/12884_2021_4360_Fig2_HTML.jpg

相似文献

1
The impact of prenatal screening tests on prenatal diagnosis in Taiwan from 2006 to 2019: a regional cohort study.2006 年至 2019 年台湾产前筛查检测对产前诊断的影响:一项区域性队列研究。
BMC Pregnancy Childbirth. 2022 Jan 9;22(1):23. doi: 10.1186/s12884-021-04360-w.
2
Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.在丹麦临床环境中使用游离胎儿 DNA 进行有条件的早孕期筛查非整倍体。
Ultrasound Obstet Gynecol. 2018 Apr;51(4):470-479. doi: 10.1002/uog.17562. Epub 2018 Mar 4.
3
Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.在中国一个试点城市,非侵入性产前检测在 21 三体、18 三体、13 三体和性染色体非整倍体的一线筛查中表现出良好的临床性能。
Hum Genomics. 2020 Jun 5;14(1):21. doi: 10.1186/s40246-020-00268-2.
4
National data on the early clinical use of non-invasive prenatal testing in public and private healthcare in Denmark 2013-2017.丹麦 2013-2017 年公共和私人医疗保健中无创性产前检测的早期临床应用的国家数据。
Acta Obstet Gynecol Scand. 2021 May;100(5):884-892. doi: 10.1111/aogs.14052. Epub 2021 Feb 24.
5
Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.应用 IONA 测试的双胎妊娠游离胎儿 DNA 非侵入性产前筛查:一项前瞻性多中心研究。
Am J Obstet Gynecol. 2021 Jul;225(1):79.e1-79.e13. doi: 10.1016/j.ajog.2021.01.005. Epub 2021 Jan 15.
6
Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.常规临床实践中的无创产前检测——对澳大利亚未选择人群中无创产前检测和孕早期联合筛查的一项审计
Aust N Z J Obstet Gynaecol. 2016 Feb;56(1):22-8. doi: 10.1111/ajo.12432.
7
Clinical application of a contingent screening strategy for trisomies with cell-free DNA: a pilot study.应用游离胎儿 DNA contingent 筛查策略进行三体综合征的临床研究:一项初步研究。
BMC Pregnancy Childbirth. 2019 Aug 1;19(1):274. doi: 10.1186/s12884-019-2434-0.
8
Prenatal screening for fetal aneuploidy in singleton pregnancies.单胎妊娠胎儿非整倍体的产前筛查。
J Obstet Gynaecol Can. 2011 Jul;33(7):736-750. doi: 10.1016/S1701-2163(16)34961-1.
9
TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.TRIDENT-2:荷兰全国范围内实施全基因组非侵入性产前筛查作为一级筛查检测。
Am J Hum Genet. 2019 Dec 5;105(6):1091-1101. doi: 10.1016/j.ajhg.2019.10.005. Epub 2019 Nov 7.
10
Prenatal diagnostic testing and atypical chromosome abnormalities following combined first-trimester screening: implications for contingent models of non-invasive prenatal testing.产前诊断检测与联合早孕期筛查后的非典型染色体异常:对非侵入性产前检测的条件模型的影响。
Ultrasound Obstet Gynecol. 2018 Apr;51(4):487-492. doi: 10.1002/uog.18979.

引用本文的文献

1
Automatic Single-Cell Harvesting for Fetal Nucleated Red Blood Cell Isolation on a Self-Assemble Cell Array (SACA) Chip.用于在自组装细胞阵列(SACA)芯片上分离胎儿有核红细胞的自动单细胞收获技术。
Micromachines (Basel). 2024 Dec 20;15(12):1515. doi: 10.3390/mi15121515.
2
The implementation and impact of non-invasive prenatal testing (NIPT) for Down's syndrome into antenatal screening programmes: A systematic review and meta-analysis.非侵入性产前检测(NIPT)在唐氏综合征产前筛查项目中的实施和影响:系统评价和荟萃分析。
PLoS One. 2024 May 16;19(5):e0298643. doi: 10.1371/journal.pone.0298643. eCollection 2024.
3
Down Syndrome Screening among Pregnant Women Visiting the Department of Obstetrics and Gynaecology of a Tertiary Care Centre.

本文引用的文献

1
Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226.筛查胎儿染色体异常:ACOG 实践公告,第 226 号。
Obstet Gynecol. 2020 Oct;136(4):e48-e69. doi: 10.1097/AOG.0000000000004084.
2
Current use of noninvasive prenatal testing in Europe, Australia and the USA: A graphical presentation.当前在欧洲、澳大利亚和美国使用的非侵入性产前检测:图形展示。
Acta Obstet Gynecol Scand. 2020 Jun;99(6):722-730. doi: 10.1111/aogs.13841. Epub 2020 Apr 3.
3
Sequencing of Circulating Cell-free DNA during Pregnancy.孕期循环游离 DNA 测序。
唐氏综合征筛查在妇产科就诊孕妇中的应用。
JNMA J Nepal Med Assoc. 2023 Oct 1;61(266):807-810. doi: 10.31729/jnma.8293.
4
Prenatal screening tests and prevalence of fetal aneuploidies in a tertiary hospital in Thailand.泰国一家三级医院的产前筛查检测与胎儿非整倍体的流行率。
PLoS One. 2023 Apr 20;18(4):e0284829. doi: 10.1371/journal.pone.0284829. eCollection 2023.
5
False-positives and false-negatives in non-invasive prenatal testing (NIPT): what can we learn from a meta-analyses on > 750,000 tests?无创产前检测(NIPT)中的假阳性和假阴性:从超过750,000次检测的荟萃分析中我们能学到什么?
Mol Cytogenet. 2022 Aug 19;15(1):36. doi: 10.1186/s13039-022-00612-2.
N Engl J Med. 2018 Aug 2;379(5):464-473. doi: 10.1056/NEJMra1705345.
4
Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis.母体血液游离 DNA 分析在非整倍体筛查中的应用:更新的荟萃分析。
Ultrasound Obstet Gynecol. 2017 Sep;50(3):302-314. doi: 10.1002/uog.17484. Epub 2017 Jul 27.
5
Positive Attitudes towards Non-Invasive Prenatal Testing (NIPT) in a Swedish Cohort of 1,003 Pregnant Women.瑞典1003名孕妇队列对无创产前检测(NIPT)的积极态度。
PLoS One. 2016 May 19;11(5):e0156088. doi: 10.1371/journal.pone.0156088. eCollection 2016.
6
Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities.游离胎儿 DNA 检测与序贯筛查在胎儿染色体异常检测中的应用比较。
Am J Obstet Gynecol. 2016 Jun;214(6):727.e1-6. doi: 10.1016/j.ajog.2015.12.018. Epub 2015 Dec 18.
7
Detection of fetal copy number variants by non-invasive prenatal testing for common aneuploidies.通过常见非整倍体的无创产前检测来检测胎儿拷贝数变异
Ultrasound Obstet Gynecol. 2016 Jan;47(1):53-7. doi: 10.1002/uog.14911.
8
Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis.羊膜穿刺术和绒毛取样术后与操作相关的流产风险:一项系统评价和荟萃分析。
Ultrasound Obstet Gynecol. 2015 Jan;45(1):16-26. doi: 10.1002/uog.14636.
9
Extended first-trimester screening using multiple sonographic markers and maternal serum biochemistry: a five-year prospective study.使用多种超声标志物和母体血清生化指标进行孕早期延长筛查:一项为期五年的前瞻性研究。
Fetal Diagn Ther. 2014;35(4):296-301. doi: 10.1159/000357564. Epub 2014 Feb 6.
10
From Down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan.从唐氏综合征筛查到无创产前检测:台湾地区20年经验
Taiwan J Obstet Gynecol. 2013 Dec;52(4):470-4. doi: 10.1016/j.tjog.2013.10.003.